There are 883 resources available
77P - Efficacy and safety of iparomlimab and tuvonralimab (QL1706) in untreated metastatic colorectal cancer (mCRC)
Presenter: Jin Li
Session: Poster Display session
Resources:
Abstract
78P - Design and optimization of colorectal cancer neoantigens mRNA vaccines with a naturel TLR-stimulating adjuvant
Presenter: Saber Imani
Session: Poster Display session
Resources:
Abstract
79P - The role of regorafenib for metastatic colorectal cancer in the new era of later-line treatment: Results of the OSERO study
Presenter: Toshihiko Matsumoto
Session: Poster Display session
Resources:
Abstract
80P - Split-course hypofraction radiotherapy combined with chemotherapy and tislelizumab as preoperative treatment for locally advanced rectal cancer: Interim analysis of a prospective, single-arm phase II trial
Presenter: Benhua Xu
Session: Poster Display session
Resources:
Abstract
81P - Stereotactic body radiation therapy followed by fruquintinib in combination with immunotherapy as third- and later-line treatment in metastatic colorectal cancer
Presenter: Yi Wang
Session: Poster Display session
Resources:
Abstract
82P - Results from FRONT study: A multicenter, randomized, open-label clinical trial of fruquintinib as maintenance therapy after 1L treatment in metastatic colorectal cancer (mCRC)
Presenter: Xiaojing Xu
Session: Poster Display session
Resources:
Abstract
83P - Efficacy and safety of cetuximab plus raltitrexed as first-line maintenance therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC): An interim analysis of a multi-center phase II trial
Presenter: XiaoYou Li
Session: Poster Display session
Resources:
Abstract
84P - A multi-centre analysis of metastatic colorectal cancer diagnosed under the age of 35: A molecularly distinct group?
Presenter: Colin Williams
Session: Poster Display session
Resources:
Abstract
85P - ZNF334 contributes to 5-fluorouracil sensitivity in colorectal cancer by ubiquitination modification of CDK1-cylin B1
Presenter: Ran Sun
Session: Poster Display session
Resources:
Abstract
86P - Impact of renal impairment on chemotherapy-induced neutropenia in patients who are treated with trifluridine/thymidine phosphorylase inhibitor + bevacizumab for metastatic colorectal cancer
Presenter: Masatsune Shibutani
Session: Poster Display session
Resources:
Abstract